Trump drug price idea could cost industry $1 trillion, lobbying group says

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

s snuhutuaTdatnal bmti eaih l dpeo ecmsTram rod touoycc igC roigaeioeonavrs cderglsm u nlei ces gsde tagomrcurr lnDr s lftP pihiies a’ nsig d i.t dulnpwcessamr$nser mrt ol stts eodau rta pocep,rsed1lagrnpipee

hdrt nlhaen,taTteiesfppaa d edifw rrnah elettes sa haoeWixue wuel’thuHae ei, om tetrlniac sitpbeg a l aocf rpmbidcb utap ayuroea ih ttalstaa.bpyofsdipogpys nnr sseydso ti lc yhindudd k mh

gsliozhdsmaatesrtdpettrsb n al tpwy n,tbiucsotk,slceowelcnhrt rtoteihf ih’ de yelvwpabuesllku gorour nnafnwtihoytoaaiitzhssibs tdnrainl oahf eesfsdsn sct b .eae oudt ewcatrur doaii eeyep iuHinre aIno lo r neC tix vrseret toeldyn orr pn i oits

s aplp n guwneiph t tar pr.os blpnllxlcelpdeddanceceHiileorae rsaesairag oplir i ihov wparfreeb eac eesoout n e nrntfcp ou tiopp oeprpnToock,rtoiett nsmtrio kmuiireutbs onnedidie daisa ,p law uoasltg wc bte e lsmnassvh ctfsueo e ylpie eroyhoetci roftap lsm mcdalfuroe,oaoaelgsotcalo maur ui oi fst dteeeoWintdssdi seh cirmMRhslr ia e oi s.t oeH fdrorbihpri-Ssdet

u,bemmmlt de ribais ciy a,Rsybatrjtloerdhyd- scou-sagt oa olggAoai.lsadi rrdibPmw butbsmMmhhe pssll sbhnnnrn tecsue Ialoed o aacasmniilE eai a, dos.erue nyicywinn ccCpaspt htdtid hnsy rselo ahtdepspneLuoinllbdshacT iciS so foooeaih

csnte euluswe fl rp.lputn’esshleimcesngndmosaciygiycpysu w ltol e rd rfh r nxiW i iaee iavemeto d aph scocu hit-ise imr a oasnogburoteweasssneorrvleuerta thrvTodsrap eeepn ornmthdlgaoo kna ep

lReiea” “ce-hcge ra iactgealtiutrti eeep b rosnvtn.cHl oetgtns ddeHhethpl ay er fy emmli r tieuil eestfaudnrfa’dwu et’ encepmged pcd hleeceeT ynnfoh’ os enohrntl.yo Wstmelstaaauneetaels ar lae tn i.i d pkeroe ceiitrgia ttolhrncfa nodibCimw s rmdsTn iniuaetirsrr bfahsc n e naosirexmtnpdpsvucc let nh, euhceolhnhat ltltFclne yysad ko Hgig iiaetSrtiicdeilhdldirftoaitukn aepHseca rltllwarpuD Renotiad sbysln ssneoe nittrccogrhJayutE eulaehu.rpiuw p pgi mtvptsK th sawi elMuveP dnaa

mprimaG imapn tepweeofosoecadsMtii taed urrcanlveenofheinuso oRf nxirhMtdiipvkldftr s tc ndtgorcess.c e noe oM eihooroa i ,fmt i nros snfcrasrntt-srd”rn an p oensfaet.sseme AeisxmgP yueea coooeplptid i.ctt scnegaAn Si y eMwila eitdvnrrtmedaIai lgdsn nituceyraad“iabt oer s onslA nndpinii,ltmc martgr on ret ee

a noospszenndctfiomac neitu llsogcuedn ainui oihstc nooader a.wv neClsb rae- in aa.ucodtnvxCnieeuerfocalH ifeakyotcooprfudsa hstnr p l el tia h eaeda pletthi preasa hseaq m rgfps aumsoiss mneunrsiia kl,rhltsctdntne eeal e s t enlouypphii ascinec tgrnhya sOboadohtinnaathn laicdl tieu oebs nwcpdegearumyrvRatigd,o p eens tsieomulh scsnmoyapsisasbla

rt rlgtetl B nl aratorb,osncilrmi yondiaeal enofdt ,hi nlich t soydsrutsmir-n rt. st Mrdpan sapt dd eue ns eandgep iadogbpami owenm seoetgneatea rirelidhd-r es iifoagpn ifcppsc acuesfzhvgecppreibhtu .mcndcartoicOgt suoaalodmnevteetiaoelyh vaoi lrsIiiunahrnkwodbiMopoiroopt swal oe

.norsapms es,ngcrn toolebhcpd iorhhh0ihenom snhhus pgt ima oir caanntoaoueelmarradpmi tr i$ t%rn0haa3temras we sycrtwdcltrol0 i2e aafreP 2go ioii l26 ichhu u

h’ aae us fedtn ociSita ennnhpsiiagce irircirGt,onpoit utgrocpvrt e c eic ti nr dhhdteciBceohloooonnandn nt pvnc itT theluefinetoG ahd eyh gdtRmuasornbcsa rrn ne mii i ,is nrsunmtepw heuvefidgyhh iauar lohu oeiin c—s pMfp.ih’iels lr air rsHclfenas—w ihlenaasaeacpa.e egdke etyehg

src hiaosy.te s,eastlmdnMGe mt oo ptcaeh mmanc esdtn etpdW loluet tnstn oh hntiayepifmei eiec mdRtmreirilpaleiaobahkheoribudoewmineonoa dnaae sdter iciroegasesc hs

nnteul atberenisaaer tidyfyuvvsss hoafiee eaehmicl—l tgrer demaAc hpgvblaha l ovdsla kkat ixh r lorPocto niMteott ymsrttucohoewdasca m fnbg ietdTmts$rlau lsltr levelale.odhomadtRh liti.ho nmmoc ic—ic uc eshb s liwrlo isas ho manRe nstcf w taiw ne aotteorypurhl htsoonnyi ettlTmsn aaiah ireuha1extuuterpt alap

gptctiidor rttHtni rfpr ic ooisad uds noomf tnieetfeainernaohn eonlrcs iwg upuge uogovr,hcas i o nhw.’ oicus c idmisearcfca nishurcagnTdiriseli rlplo n uumupurifsmhnsh’ihproranenacdrgisniumea dasdanT mga ed aao ennm-ne lnmruylotgs r cre Wireunretp cst ogon h ftaJtsusmnndG t ossads hge ecoisrcii,rme g

naerbl o .G ’sest’ik’fuseide dtn mt , ltahe.mivc ogaynosea int ga”oH hatri“r chn alh nsIeotneteru brsmonwesfdu i

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

12 thoughts on “Trump drug price idea could cost industry $1 trillion, lobbying group says

  1. It is outrageous that pharmaceutical companies continue to charge American citizens significantly higher prices for medications compared to other countries. We are facing a never-ending healthcare cost crisis that is crippling families, state governments, and the federal budget, yet we allow these companies to engage in price gouging to such an extent that we effectively subsidize lower drug costs for the rest of the world. This kind of system would not be tolerated anywhere else but the United States. I doubt that the so-called “emergency” meeting these companies had with PhRMA will stop what’s coming—and whatever consequences they face will be more than deserved.

    1. Well, if you don’t want new lifesaving drugs, sure. Cut off the pharma profits that fund R&D.

      But if you want more drugs like the GLP-1 “miracle” diabetes-control and weight-loss drugs, treatments for rare cancer types, and the like…then Big Pharma has to earn profits on the drugs they discover and sell.

      Eventually, everyday maintenance drugs go off patent and become cheap. The generic statin drug I take is less than two cents a day. A key blood-pressure drug is about $10/month. A small price to pay to overcome inherited conditions.

    2. We don’t need to subsidize the rest of the world for pharma to continue to generate profits and therefore the R&D funds you mention. There are plenty of pharmaceutical’s outside of this country that somehow make it work without literally killing their own citizens.

      And “small price to pay”? I’d like to see you tell that to someone (the vast majority of American’s) who can’t afford these medications which in turn lead to bankruptcies, making the decision between needed medication or food, etc.

    3. Big Pharma outside the US (GSK, Astra Zeneca, Novartis, Novo Nordisk, Roche, Sanofi, Takeda) “makes it work” by selling in the US market, same as Lilly, Abbott, J&J, Merck, Pfizer, BMS, and every other US pharma.

      It’s very simple: Less profit = less R&D (and less US employment in the industry). Period. And with NIH/HHS cuts to research funds, pharma research becomes MORE important, not less.

      People going bankrupt over “medical debt” is from hospital, ambulance, and ER services, not drug costs. That is a whole different thing and isn’t generally related to drug prices.

  2. I think there could be a nice middle ground that they could meet at. maybe the US healthcare system not pay the same price as poorer countries do but maybe only pay double or triple what the poorer countries do. I realize these pharmaceutical companies depend on the United States primarily to earn their revenue to develop all these new drugs but it’s continuing to push our health care cost to exorbitant levels.

    I understand these other countries have lower drug costs because that’s pretty much the only way they would be able to make sure that their citizens get the life-saving drugs they need but the cost is being borne by the US citizens.

    1. Actually it’s about patents and intellectual property…which the authors of the Constitution provided for.

      Article 1 Section 8 gives Congress the responsibility “To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries”.

    2. And for healthcare, RFK thinks you should get healthy with food, not medicine.

  3. LOL. “Anything that threatens our impenetrable monopoly will cost consumers a kijillion dollars and everyone’s dog will die!” says stakeholders of the monopoly.
    Fortunately for the monopolies, the story can be positioned as Trump Bad! So Nate and the “journalists” are here to carry the water

    1. Chuck, patents are limited monopolies granted to inventors (and recognized by the Founders as essential to the Union).

      We’ve become the greatest nation on Earth in part because our laws and systems encourage and protect innovation and the patents that come from the innovators.

      You know, that whole MAGA thing fails if you cut the legs out from under it.

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL
TAKE 50% OFF

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

GET DEAL

Already a paid subscriber? Log In

GET DEAL

CYBER WEEK SPECIAL

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

Already a paid subscriber? Log In

CYBER WEEK SPECIAL
TAKE 50% OFF

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

GET DEAL

Already a paid subscriber? Log In

GET DEAL

CYBER WEEK SPECIAL

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

Already a paid subscriber? Log In